Skip to main content
SpringerLink
Log in

Nasopharyngeal Carcinoma

  • Chapter
  • First Online:
Rare Tumors in Children and Adolescents

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 773 Accesses

Abstract

Nasopharyngeal carcinoma (NPC) is a rare malignant tumor in childhood not only in Europe but also in Asia, where the highest incidence of NPC in adult patients is seen. NPC represents one of the most frequent epithelial tumors of the child in intermediate-risk regions. However, distinguishing malignant tumors from the more common and numerous benign causes of neck masses in childhood is crucial, as many malignant conditions have an excellent prognosis with appropriate oncological management, but with long-term effects that require long-term surveillance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Afquir S, Alaoui K, Ismaili N et al (2009) Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients. Eur Arch Otorhinolaryngol 266:1767–1773

    Article  Google Scholar 

  • Altun M, Fandi A, Dupuis O, Cvitkovic E, Krajina Z, Eschwege F (1995) Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys 32(3):859–877

    Article  CAS  PubMed  Google Scholar 

  • Amin MB, Edge SB, Greene FL et al (eds) (2017) AJCC cancer staging manual, 8th edn. Springer, New York, pp 103–111

    Google Scholar 

  • Ayan I, Kaytan E, Ayan N (2003) Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol 4:13–21

    Article  CAS  PubMed  Google Scholar 

  • Belmont JR (1988) The Le Fort I osteotomy approach for nasopharyngeal and nasal fossa tumors. Arch Otolaryngol Head Neck Surg 114:751–754

    Article  CAS  PubMed  Google Scholar 

  • Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP, MAC-NPC Collaborative Group (2015) Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol 16(6):645–655

    Article  PubMed  Google Scholar 

  • Borghei P, Baradaranfar MH, Borghei SH, Sokhandon F (2006) Transnasal endoscopic resection of juvenile nasopharyngeal angiofibroma without preoperative embolization. Ear Nose Throat J 85:740–743, 746

    Article  PubMed  Google Scholar 

  • Bornkamm GW (1984) Virologisch-serologische Diagnostik des Nasopharynxkarzinoms. In: Nasopharynx-Tumoren. Urban & Schwarzenberg, München-Wien-Baltimore, pp 15–21

    Google Scholar 

  • Bray F, Haugen M et al (2008) Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomark Prev 17(9):2356–2365

    Article  Google Scholar 

  • Buehrlen M, Zwaan C, Granzen B et al (2012) Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults. Cancer 118:4892–4900

    Article  CAS  PubMed  Google Scholar 

  • Butler EB, Teh BS, Grant WH 3rd, Uhl BM, Kuppersmith RB, Chiu JK et al (1999) Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45(1):21–32

    Article  CAS  PubMed  Google Scholar 

  • Cai YL, Zheng YM, Cheng JR, Wang W, Zhang YN, Wang WH, Wu YS, Zhong WM, Li J, Mo YK (2010) Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA. Nan Fang Yi Ke Da Xue Xue Bao 30(3):509–511

    PubMed  Google Scholar 

  • Casanova M, Bisogno G, Gandola L, Cechetto G, Di Cataldo A, Basso E, Indolfi P, D’Angelo P, Favini F, Collini P, Potepan P, Ferrari A (2012) A prospective protocol for nasopharyngeal carcinoma in children and adolescents. Cancer 118:2718–2725

    Article  PubMed  Google Scholar 

  • Casanova M, Özyar E, Patte C, Orbach D, Ferrari A, Veyrat-Follet C, Errihani H, Pan J, Zhang L, Shen L, Grzegorzewski KJ, Varan A (2016) International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents. Cancer Chemother Pharmacol 77:289–298

    Article  CAS  PubMed  Google Scholar 

  • Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, Zong YS, Ng MH (2003) EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer 105(5):706–709

    Article  CAS  PubMed  Google Scholar 

  • Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev 15(10):1765–1777

    Article  CAS  Google Scholar 

  • Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ (2011) Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst 103(23):1761–1770

    Article  PubMed  Google Scholar 

  • Cheng JC, Chao KS, Low D (2001) Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 96(2):126–131

    Article  CAS  PubMed  Google Scholar 

  • Cheuk DK, Billups CA, Martin MG, Roland CR, Ribeiro RC, Krasin MJ, Rodriguez-Galindo C (2011) Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma. Cancer 117(1):197–206

    Article  CAS  PubMed  Google Scholar 

  • Cheuk DK, Sabin ND, Hossain M, Wozniak A, Najk M (2012) PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging 39:1097–1106

    Article  PubMed  PubMed Central  Google Scholar 

  • Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS (2001) Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345(26):1877–1882

    Article  CAS  PubMed  Google Scholar 

  • Chong VF, Fan YF, Khoo JB (1996) Nasopharyngeal carcinoma with intracranial spread: CT and MR characteristics. J Comput Assist Tomogr 20(4):563–569

    Article  CAS  PubMed  Google Scholar 

  • Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD (2018) NCCN guidelines insights: head and neck cancers, version 1.2018. J Natl Compr Cancer Netw 16(5):479–490

    Article  Google Scholar 

  • Comoli P, Pedrazzoli P, Maccario R et al (2005) Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. J Clin Oncol 23:8942–8949

    Article  CAS  PubMed  Google Scholar 

  • de Vathaire F, Sancho-Garnier H, de Thé H, Pieddeloup C, Schwaab G, Ho JH, Ellouz R, Micheau C, Cammoun M, Cachin Y et al (1988) Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study. Int J Cancer 42(2):176–181

    Article  Google Scholar 

  • Dittmer DP, Hilscher CJ, Gulley ML, Yang EV, Chen M, Glaser R (2008) Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma. Int J Cancer 123(9):2105–2112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dourthe ME, Bolle S, Temam S, Jouin A, Claude L, Reguerre Y, Defachelles AS, Orbach D, Fresneau B (2018) Childhood nasopharyngeal carcinoma: state-of-the-art, and questions for the future. J Pediatr Hematol Oncol 40(2):85–92. https://doi.org/10.1097/MPH.0000000000001054. PMID: 29300240

  • Dubey SP, Molumi CP (2007) Critical look at the surgical approaches of nasopharyngeal angiofibroma excision and “total maxillary swing” as a possible alternative. Ann Otol Rhinol Laryngol 116:723–730

    Article  PubMed  Google Scholar 

  • Elser C, Siu LL, Winquist E, Agulnik M, Pond GR, Chin SF, Francis P, Cheiken R, Elting J, McNabola A, Wilkie D, Petrenciuc O, Chen EX (2007) Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma. J Clin Oncol 25(24):3766–3773

    Article  CAS  PubMed  Google Scholar 

  • Fandi A, Bachouchi M, Azli N, Taamma A, Boussen H, Wibault P, Eschwege F, Armand JP, Simon J, Cvitkovic E (2000) Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol 18(6):1324–1330

    Article  CAS  PubMed  Google Scholar 

  • Fang FM, Chiu HC, Kuo WR, Wang CJ, Leung SW, Chen HC et al (2002) Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. Int J Radiat Oncol Biol Phys 53(4):959–968

    Article  PubMed  Google Scholar 

  • Fotheringham JA, Mazzucca S, Raab-Traub N (2010) Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63 alpha expression is associated with impaired epithelial-cell differentiation. Oncogene 29(30):4287–4296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fujii M, Yamashita T, Ishiguro R, Tashiro M, Kameyama K (2002) Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma. Auris Nasus Larynx 29(2):175–181

    Article  PubMed  Google Scholar 

  • Ghim TT, Briones M, Mason P et al (1998) Effective adjuvant chemotherapy for advanced nasopharyngeal carcinoma in children: a final update of a long-term prospective study in a single institution. J Pediatr Hematol Oncol 20:131–135

    Article  CAS  PubMed  Google Scholar 

  • Glad H, Vainer B, Buchwald C, Petersen BL, Theilgaard SA, Bonvin P, Lajer C, Jakobsen J (2007) Juvenile nasopharyngeal angiofibromas in Denmark 1981–2003: diagnosis, incidence, and treatment. Acta Otolaryngol 127:292–299

    Article  CAS  PubMed  Google Scholar 

  • Godtfredsen E (1944) Chapter III: on the histopathology of malignant nasopharyngeal tumours. Acta Pathol Microbiol Scand 32(Suppl 59):38–56

    Google Scholar 

  • Goepfert H, Cangir A, Lee YY (1985) Chemotherapy for aggressive juvenile nasopharyngeal angiofibroma. Arch Otolaryngol 111(5):285–289

    Article  CAS  PubMed  Google Scholar 

  • Gullane PJ, Davidson J, O’Dwyer T, Forte V (1992) Juvenile angiofibroma: a review of the literature and a case series report. Laryngoscope 102(8):928–933

    Article  CAS  PubMed  Google Scholar 

  • Hashizume H, Falcon BL, Kuroda T, Baluk P, Coxon A, Yu D, Bready JV, Oliner JD, McDonald DM (2010) Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth. Cancer Res 70:2213–2223

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hildesheim A, Apple RJ, Chen CJ, Wang SS, Cheng YJ, Klitz W, Mack SJ, Chen IH, Hsu MM, Yang CS, Brinton LA, Levine PH, Erlich HA (2002) Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 94(23):1780–1789

    Article  CAS  PubMed  Google Scholar 

  • Howard DJ, Lloyd G, Lund V (2001) Recurrence and its avoidance in juvenile angiofibroma. Laryngoscope 111:1509–1511

    Article  CAS  PubMed  Google Scholar 

  • Hsiung CY, Yorke ED, Chui CS, Hunt MA, Ling CC, Huang EY et al (2002) Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 53(3):638–647

    Article  PubMed  Google Scholar 

  • Hsu C, Lee SH, Ejadi S, Even C, Cohen RB, Le Tourneau C, Mehnert JM, Algazi A, van Brummelen EMJ, Saraf S, Thanigaimani P, Cheng JD, Hansen AR (2017) Safety and antitumor activity of Pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: results of the KEYNOTE-028 study. J Clin Oncol 35(36):4050–4056

    Article  CAS  PubMed  Google Scholar 

  • Huang TS, Huang SC, Hsu MM (1994) A prospective study of hypothalamus pituitary function after cranial irradiation with or without radiosensitizing chemotherapy. J Endocrinol Invest 17(8):615–623

    Article  CAS  PubMed  Google Scholar 

  • Huang SCM, Tsao SW, Tsang CM (2018) Interplay of viral infection, host cell factors and tumor microenvironment in the pathogenesis of nasopharyngeal carcinoma. Cancers (Basel) 10(4):106

    Article  CAS  Google Scholar 

  • Hui EP, Ma BB, King AD, Mo F, Chan SL, Kam MK, Loong HH, Ahuja AT, Zee BC, Chan AT (2011) Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation. Ann Oncol 22(6):1280–1287

    Article  CAS  PubMed  Google Scholar 

  • Jacobsson M, Petruson B, Ruth M, Svendsen P (1989) Involution of juvenile nasopharyngeal angiofibroma with intracranial extension. A case report with computed tomographic assessment. Arch Otolaryngol Head Neck Surg 115:238–239

    Article  CAS  PubMed  Google Scholar 

  • Jouin A, Helfre S, Bolle S, Claude L, Laprie A, Bogart E, Vigneron C, Potet H, Ducassou A, Claren A, Riet FG, Castex MP, Faure-Conter C, Fresneau B, Defachelles AS, Orbach D (2019) Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience. Strahlenther Onkol 195(6):504–516

    Article  PubMed  Google Scholar 

  • Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F et al (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25(31):4873–4879

    Article  PubMed  Google Scholar 

  • King AD, Ma BB, Yau YY, Zee B, Leung SF, Wong JK, Kam MK, Ahuja AT, Chan AT (2008) The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol 81(964):291–298

    Article  CAS  PubMed  Google Scholar 

  • Kontny U, Franzen S, Behrends U, Bührlen M, Christiansen H, Delecluse H, Eble M, Feuchtinger T, Gademann G, Granzen B, Kratz CP, Lassay L, Leuschner I, Mottaghy FM, Schmitt C, Staatz G, Timmermann B, Vorwerk P, Wilop S, Wolff HA, Mertens R (2016) Diagnosis and treatment of nasopharyngeal carcinoma in children and adolescents—recommendations of the GPOH-NPC Study Group. Klin Padiatr 228:105–112

    Article  CAS  PubMed  Google Scholar 

  • Krueger GRF, Wustrow J (1981) Current classification of nasopharyngeal carcinoma at Cologne University. In: Grundmann E, Krueger GRF, Ablashi DV (eds) Nasopharyngeal carcinoma, vol 5. Gustav Fischer Verlag, Stuttgart, pp 11–15

    Google Scholar 

  • Labra A, Chavolla-Magaña R, Lopez-Ugalde A, Alanis-Calderon J, Huerta-Delgado A (2004) Flutamide as a preoperative treatment in juvenile angiofibroma (JA) with intracranial invasion: report of 7 cases. Otolaryngol Head Neck Surg 130(4):466–699

    Article  PubMed  Google Scholar 

  • Lee DA, Rao BR, Meyer JS, Prioleau PG, Bauer WC (1980) Hormonal receptor determination in juvenile nasopharyngeal angiofibromas. Cancer 46:547–551

    Article  CAS  PubMed  Google Scholar 

  • Lee AW, Foo W, Law SC, Poon YF, Sze WM, O S K, Tung SY, Lau WH (1997) Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J 3(4):355–361

    PubMed  Google Scholar 

  • Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L et al (2005a) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23(28):6966–6975

    Article  CAS  PubMed  Google Scholar 

  • Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, Kwong DL, Lau WH (2005b) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61(4):1107–1116

    Article  PubMed  Google Scholar 

  • Leong SS, Wee J, Rajan S, Toh CK, Lim WT, Hee SW, Tay MH, Poon D, Tan EH (2008) Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma. Cancer 113(6):1332–1337

    Article  CAS  PubMed  Google Scholar 

  • Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ et al (2003) Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Cancer 98(2):288–291

    Article  PubMed  Google Scholar 

  • Leung SF, Zee B, Ma BB, Hui EP, Mo F, Lai M, Chan KC, Chan LY, Kwan WH, Lo YM, Chan AT (2006) Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol 24(34):5414–5418

    Article  CAS  PubMed  Google Scholar 

  • Liang J, Yi Z, Lianq P (2000) The nature of juvenile nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg 123:475–481

    Article  CAS  PubMed  Google Scholar 

  • Liebowitz D (1994) Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol 21(3):376–381

    CAS  PubMed  Google Scholar 

  • Lim WT, Ng QS, Ivy P, Leong SS, Singh O, Chowbay B, Gao F, Thng CH, Goh BC, Tan DS, Koh TS, Toh CK, Tan EH (2011) A phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinoma. Clin Cancer Res 17(16):5481–5489

    Article  CAS  PubMed  Google Scholar 

  • Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS et al (2004) Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350(24):2461–2470

    Article  CAS  PubMed  Google Scholar 

  • Lin J, Xie G, Liao G, Wang B, Yan M, Li H, Yuan Y (2017) Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systemic review and metaanalysis. Oncotarget 8:33884–33896

    Article  PubMed  Google Scholar 

  • Liu FY, Chang JT, Wang HM, Liao CT, Kang CJ, Ng SK, Chan SC, Yen TC (2008) (18F) Fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol 24:599–604

    Article  CAS  Google Scholar 

  • Lloyd C, McHugh K (2010) The role of radiology in head and neck tumours in children. Cancer Imaging 10:49–61

    Article  PubMed  PubMed Central  Google Scholar 

  • Lo YM, Leung SF, Chan LY, Chan AT, Lo KW, Johnson PJ et al (2000) Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res 60(9):2351–2355

    CAS  PubMed  Google Scholar 

  • Lo AK, Dawson CW, Jin DY, Lo KW (2012) The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J Pathol 227(4):392–403

    Article  CAS  PubMed  Google Scholar 

  • López F, Triantafyllou A, Snyderman CH, Hunt JL, Suárez C, Lund VJ, Strojan P, Saba NF, Nixon IJ, Devaney KO, Alobid I, Bernal-Sprekelsen M, Hanna EY, Rinaldo A, Ferlito A (2017) Nasal juvenile angiofibroma: current perspectives with emphasis on management. Head Neck 39(5):1033–1045

    Article  PubMed  Google Scholar 

  • Louis CU, Straathof K, Bollard CM et al (2010) Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother 33:983–990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ma BBY, Lim WT, Goh BC, Hui EP, Lo KW, Pettinger A, Foster NR, Riess JW, Agulnik M, Chang AYC, Chopra A, Kish JA, Chung CH, Adkins DR, Cullen KJ, Gitlitz BJ, Lim DW, To KF, Chan KCA, Lo YMD, King AD, Erlichman C, Yin J, Costello BA, Chan ATC (2018) Antitumor activity of Nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic phase 2 consortium (NCI-9742). J Clin Oncol 36(14):1412–1418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Makowska A, Wahab L, Braunschweig T, Kapetanakis N, Vokuhl C, Denecke B, Shen L, Busson P, Kontny U (2018) Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAIL-signaling pathway. Oncotarget 9:14228–14250

    Article  PubMed  PubMed Central  Google Scholar 

  • Makowska A, Braunschweig T, Denecke B, Shen L, Baloche V, Busson P, Kontny U (2019a) Interferon beta and anti-PD-1/PD-L1 checkpoint blockade cooperate in NK cell-mediated killing of nasopharyngeal carcinoma cells. Transl Oncol 12(9):1237–1256

    Article  PubMed  PubMed Central  Google Scholar 

  • Makowska A, Franzen S, Braunschweig T, Denecke B, Shen L, Baloche V, Busson P, Kontny U (2019b) Interferon-beta increases NK cell cytotoxicity against tumor cells in patients with nasopharyngeal carcinoma via tumor necrosis factor apoptosis-inducing ligand. Cancer Immunol Immunother 68(8):1317–1329

    Article  CAS  PubMed  Google Scholar 

  • Mann WJ, Jecker P, Amedee RG (2004) Juvenile angiofibromas: changing surgical concept over the last 20 years. Laryngoscope 114:291–293

    Article  PubMed  Google Scholar 

  • Marks JE, Phillips JL, Menck HR (1998) The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83(3):582–588

    Article  CAS  PubMed  Google Scholar 

  • McMillan AS, Pow EH, Leung WK, Wong MC, Kwong DL (2004) Oral health-related quality of life in southern Chinese following radiotherapy for nasopharyngeal carcinoma. J Oral Rehabil 31(6):600–608

    Article  CAS  PubMed  Google Scholar 

  • Mertens R, Lassay L, Heimann G (1993) Combined treatment of nasopharyngeal cancer in children and adolescents—concept of a study. Klin Padiatr 205:241–248

    Article  CAS  PubMed  Google Scholar 

  • Mertens R, Granzen B, Lassay L, Bucsky P, Hundgen M, Stetter G, Heimann G, Weiss C, Hess CF, Gademann G (2005) Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH). Cancer 104(5):1083–1089

    Article  PubMed  Google Scholar 

  • Micheau C, Rilke F, Pilotti S (1978) Proposal for a new histopathological classification of the carcinomas of the nasopharynx. Tumori 64(5):513–518

    Article  CAS  PubMed  Google Scholar 

  • Mutirangura A, Pornthanakasem W, Theamboonlers A, Sriuranpong V, Lertsanguansinchi P, Yenrudi S, Voravud N, Supiyaphun P, Poovorawan Y (1998) Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res 4(3):665–669

    CAS  PubMed  Google Scholar 

  • Ngan BY, Forte V, Campisi P (2008) Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy. Arch Otolaryngol Head Neck Surg 134:1170–1176

    Article  PubMed  Google Scholar 

  • Nicolai P, Berlucchi M, Tomenzoli D, Cappiello J, Trimarchi M, Maroldi R, Battaglia G, Antonelli AR (2003) Endoscopic surgery for juvenile angiofibroma: when and how. Laryngoscope 113:775–782

    Article  PubMed  Google Scholar 

  • Niedobitek G, Young LS (1994) Epstein-Barr virus persistence and virus-associated tumors. Lancet 343:333–335

    Article  CAS  PubMed  Google Scholar 

  • Orbach D, Brisse H, Helfre S et al (2008) Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: radiotherapy dose adaptation after chemotherapy response to minimize late effects. Pediatr Blood Cancer 50:849–853

    Article  PubMed  Google Scholar 

  • Ozyar E, Selek U, Laskar S et al (2006) Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study. Radiother Oncol 81:39–46

    Article  PubMed  Google Scholar 

  • Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, Han J, Wu G (2012) A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 104(3):286–293

    Article  PubMed  Google Scholar 

  • Perri F, Della Vittoria Scarpati G, Caponigro F, Ionna F, Longo F, Buonopane S, Muto P, Di Marzo M, Pisconti S, Solla R (2019) Management of recurrent nasopharyngeal carcinoma: current perspectives. Onco Targets Ther 12:1583–1591

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66(4):981–991

    Article  PubMed  Google Scholar 

  • Reddy KA, Mendenhall WM, Amdur RJ, Stringer SP, Cassisi NJ (2001) Long-term results of radiation therapy for juvenile nasopharyngeal angiofibroma. Am J Otolaryngol 22:172–175

    Article  CAS  PubMed  Google Scholar 

  • Ren ZF, Liu WS, Qin HD, Xu YF, Yu DD, Feng QS, Chen LZ, Shu XO, Zeng YX, Jia W (2010) Effect of family history of cancers and environmental factors on risk of nasopharyngeal carcinoma in Guangdong, China. Cancer Epidemiol 34(4):419–424

    Article  PubMed  Google Scholar 

  • Rodriguez-Galindo C, Wofford M, Castleberry RP, Swanson GP, London WB, Fontanesi J, Pappo AS, Douglass EC (2005) Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer 103(4):850–857

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez-Galindo C, Krailo MD, Krasin MJ, McCarville MB, Hicks J, Pashankar F, Pappo AS (2016) Treatment of childhood nasopharyngeal carcinoma (cNPC) with neoadjuvant chemotherapy (NAC) and concomitant chemoradiotherapy (CCRT): results of the Children’s Oncology Group ARAR0331 study. J Clin Oncol 34 (suppl; abstr 10513)

    Google Scholar 

  • Saylam G, Yucel OT, Sungur A, Onerci M (2006) Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 70:227–234

    Article  PubMed  Google Scholar 

  • Schuon R, Brieger J, Heinrich UR, Roth Y, Szyfter W, Mann WJ (2007) Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 264:389–394

    Article  PubMed  Google Scholar 

  • Sham JS, Cheung YK, Choy D, Chan FL, Leong L (1991) Nasopharyngeal carcinoma: CT evaluation of patterns of tumor spread. AJNR Am J Neuroradiol 12(2):265–270

    CAS  PubMed  PubMed Central  Google Scholar 

  • Shanmugaratnam K (1980) Nasopharyngeal carcinoma: epidemiology, histopathology and aetiology. Ann Acad Med Singap 9(3):289–295

    CAS  PubMed  Google Scholar 

  • Su WH, Hildesheim A, Chang YS (2013) Human leukocyte antigens and Epstein-Barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers. Front Oncol 3:299

    Article  PubMed  PubMed Central  Google Scholar 

  • Sultan I, Casanova M et al (2010) Differential features of nasopharyngeal carcinoma in children and adults: a SEER study. Pediatr Blood Cancer 55(2):279–284

    Article  PubMed  Google Scholar 

  • Taheri-Kadkhoda Z, Björk-Eriksson T, Nill S, Wilkens JJ, Oelfke U, Johansson K-A et al (2008) Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons. Radiat Oncol 3(1):4

    Article  PubMed  PubMed Central  Google Scholar 

  • Tao CJ, Liu X, Tang LL et al (2013) Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma. Chin J Cancer 32:525–532

    Article  PubMed  PubMed Central  Google Scholar 

  • Thakar A, Gupta G, Bhalla AS, Jain V, Sharma SC, Sharma R, Bahadur S, Deka RC (2011) Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma. Head Neck 33(12):1747–1753

    Article  PubMed  Google Scholar 

  • Tosun S, Ozer C, Gerek M, Yetiser S (2006) Surgical approaches for nasopharyngeal angiofibroma: comparative analysis and current trends. J Craniofac Surg 17:15–20

    Article  PubMed  Google Scholar 

  • Treuner J, Niethammer D, Dannecker G, Hagmann R, Neef V, Hofschneider PH (1980) Successful treatment of nasopharyngeal carcinoma with interferon. Lancet 12:817–818

    Article  Google Scholar 

  • Tyagi I, Syal R, Goyal A (2007) Recurrent and residual juvenile angiofibromas. J Laryngol Otol 121:460–467

    Article  CAS  PubMed  Google Scholar 

  • Ulger S, Ulger Z, Yildiz F, Ozyar E (2007) Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma. Med Oncol 24(1):91–94

    Article  PubMed  Google Scholar 

  • Wagner HJ, Mertens R, Reiter A, Gauch C (2009) Molecular and serological monitoring of pediatric patients with nasopharyngeal carcinoma treated by the protocol NPC-2003-GPOH of the German Society for Pediatric Oncology. Pediatr Blood Cancer 53:751

    Google Scholar 

  • Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T et al (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23(27):6730–6738

    Article  CAS  PubMed  Google Scholar 

  • Wei W, St Sham J (2005) Nasopharyngeal carcinoma. Lancet 365:2041–2054

    Article  PubMed  Google Scholar 

  • Weprin LS, Siemers PT (1991) Spontaneous regression of juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 117:796–799

    Article  CAS  PubMed  Google Scholar 

  • Widesott L, Pierelli A, Fiorino C, Dell’oca I, Broggi S, Cattaneo GM, Di Muzio N, Fazio F, Calandrino R, Schwarz M et al (2008) Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 72(2):589–596

    Article  PubMed  Google Scholar 

  • Withers HR, Thames HD (1988) Dose fractionation and volume effects in normal tissues and tumors. Am J Clin Oncol 11(3):313–329

    Article  CAS  PubMed  Google Scholar 

  • Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ (2006) Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64(1):57–62

    Article  PubMed  Google Scholar 

  • Wu VW, Kwong DL, Sham JS (2004) Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol 71(2):201–206

    Article  CAS  PubMed  Google Scholar 

  • Xie P, Yue JB, Fu Z, Feng R, Yu JM (2010) Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma. Ann Oncol 21:1078–1082

    Article  CAS  PubMed  Google Scholar 

  • Yan Z, Xia L, Huang Y et al (2013) Nasopharyngeal carcinoma in children and adolescents in an endemic area: a report of 185 cases. Int J Pediatr Otorhinolaryngol 77:1454–1460

    Article  PubMed  Google Scholar 

  • Yao JJ, Lin L, Jin YN, Wang SY, Zhang WJ, Zhang F, Zhou GQ, Cheng ZB, Qi ZY, Sun Y (2017) Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA. Cancer Sci 108(8):1640–1647

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yiotakis I, Eleftheriadou A, Davilis D, Giotakis E, Ferekidou E, Korres S, Kandiloros D (2008) Juvenile nasopharyngeal angiofibroma stages I and II: a comparative study of surgical approaches. Int J Pediatr Otorhinolaryngol 72:793–800

    Article  PubMed  Google Scholar 

  • Zaghloul MS, Eldebawy E, Ahmed S, Ammar H, Khalil E, Abdelrahman H, Zekri W, Elzomor H, Taha H, Elnashar A (2016) Does primary tumor volume predict the outcome of pediatric nasopharyngeal carcinoma ? A prospective single-arm study using neoadjuvant chemotherapy and concomitant chemotherapy with intensity modulated radiotherapy. Asia Pac J Clin Oncol 12:143–150

    Article  PubMed  Google Scholar 

  • Zhang PJ, Weber R, Liang HH, Pasha TL, LiVolsi VA (2003) Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study. Arch Pathol Lab Med 127:1480–1484

    Article  CAS  PubMed  Google Scholar 

  • Zhang W, Chen Y, Chen L, Guo R, Zhou G, Tang L, Mao Y, Li W, Liu X, Du X, Sun Y, Ma J (2015) The clinical utility of plasma Epstein-Barr virus DNA assays in nasopharyngeal carcinoma: the dawn of a new era ? A systematic review and meta-analysis of 7836 cases. Medicine (Baltimore) 94(20):e845

    Article  CAS  Google Scholar 

  • Zhang L, Huang Y, Hong S, Yang Y, Yu G, Jia J, Peng P, Wu X, Lin Q, Xi X, Peng J, Xu M, Chen D, Lu X, Wang R, Cao X, Chen X, Lin Z, Xiong J, Lin Q, Xie C, Li Z, Pan J, Li J, Wu S, Lian Y, Yang Q, Zhao C (2016) Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial. Lancet 388(10054):1883–1892

    Article  CAS  PubMed  Google Scholar 

  • Zubarreta P, D’Antonio G, Gallo G et al (2000) Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy. Cancer 89:690–695

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, RWTH Medical Faculty, Aachen, Germany

    Udo Kontny

  2. Departments of Global Pediatric Medicine and Oncology, St. Jude Children’s Research Hospital, Memphis, TN, USA

    Carlos Rodriguez-Galindo

  3. SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France

    Daniel Orbach

  4. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

    Michela Casanova

Authors
  1. Udo Kontny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Rodriguez-Galindo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel Orbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michela Casanova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Udo Kontny .

Editor information

Editors and Affiliations

  1. Clinic of Pediatrics, Municipal Hospital Dortmund, University Witten-Herdecke, Dortmund, Germany

    Dominik T. Schneider

  2. Department of Hematology and Oncology, University Children’s Hospital, Tübingen, Baden-Württemberg, Germany

    Ines B. Brecht

  3. Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, Atlanta, GA, USA

    Thomas A. Olson

  4. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Milano, Italy

    Andrea Ferrari

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kontny, U., Rodriguez-Galindo, C., Orbach, D., Casanova, M. (2022). Nasopharyngeal Carcinoma. In: Schneider, D.T., Brecht, I.B., Olson, T.A., Ferrari, A. (eds) Rare Tumors in Children and Adolescents. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-92071-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-92071-5_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-92070-8

  • Online ISBN: 978-3-030-92071-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation